Zyla Life Sciences
DelistedCIK 1586105fmd_154NBEB3W33BG7FMJETKSG17YGManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Mar 31, 2020, 30 periods
Latest annual · FY2018
Millions- Total revenues
- 30
- Operating income
- (58)
- Net income
- (95)
- Free cash flow
- (55)
Latest quarter · Q1 FY2020
Millions- Total revenues
- 19
- Operating income
- (14)
- Net income
- (18)
- Free cash flow
- 5
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2015 to FY2018
- +10.0%
- Revenue, 5 yearsFY2013 to FY2018
- n/m
- Net income, 5 yearsFY2013 to FY2018
- n/m
Zyla Life Sciences financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Revenue | $30.4 million | $26.1 million | +16.1% | 10-K 2019-03-29 · proof |
| Operating income | -$57.6 million | -$68.2 million | 10-K 2019-03-29 · proof | |
| Net income | -$95.5 million | -$69.4 million | 10-K 2019-03-29 · proof | |
| Cash from operating activities | -$54.8 million | -$65.2 million | 10-K 2019-03-29 · proof | |
| Free cash flow | -$54.8 million | -$65.3 million | 10-K 2019-03-29 · proof | |
| Total assets | $61.9 million | $119.9 million | -48.3% | 10-K 2019-03-29 · proof |
| Total liabilities | $173.3 million | $159.2 million | +8.8% | 10-K 2019-03-29 · proof |
| Cash and cash equivalents | $35.3 million | $31.1 million | +13.6% | 10-K 2019-03-29 · proof |
- What was Zyla Life Sciences's revenue in fiscal 2018?
- Zyla Life Sciences reported revenue of $30.4 million for fiscal 2018 (the year ended Dec 31, 2018), against $26.1 million the year before (+16.1%). Source: the 10-K filed with the SEC on Mar 29, 2019. SEC
- What was Zyla Life Sciences's operating income in fiscal 2018?
- Zyla Life Sciences reported operating income of -$57.6 million for fiscal 2018 (the year ended Dec 31, 2018), against -$68.2 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2019. SEC
- What was Zyla Life Sciences's net income in fiscal 2018?
- Zyla Life Sciences reported net income of -$95.5 million for fiscal 2018 (the year ended Dec 31, 2018), against -$69.4 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2019. SEC
- What was Zyla Life Sciences's cash from operating activities in fiscal 2018?
- Zyla Life Sciences reported cash from operating activities of -$54.8 million for fiscal 2018 (the year ended Dec 31, 2018), against -$65.2 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2019. SEC
- What was Zyla Life Sciences's free cash flow in fiscal 2018?
- Zyla Life Sciences reported free cash flow of -$54.8 million for fiscal 2018 (the year ended Dec 31, 2018), against -$65.3 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2019. SEC
- What are Zyla Life Sciences's total assets?
- As of Dec 31, 2018, Zyla Life Sciences reported total assets of $61.9 million, against $119.9 million a year earlier (-48.3%). Source: the 10-K filed with the SEC on Mar 29, 2019. SEC
- What are Zyla Life Sciences's total liabilities?
- As of Dec 31, 2018, Zyla Life Sciences reported total liabilities of $173.3 million, against $159.2 million a year earlier (+8.8%). Source: the 10-K filed with the SEC on Mar 29, 2019. SEC
- What are Zyla Life Sciences's cash and cash equivalents?
- As of Dec 31, 2018, Zyla Life Sciences reported cash and cash equivalents of $35.3 million, against $31.1 million a year earlier (+13.6%). Source: the 10-K filed with the SEC on Mar 29, 2019. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1586105&period_type=annual&limit=5"Information only, not investment advice.